Sigma-Aldrich and VIB to meet the needs of translational researchers
Sigma-Aldrich’s Research business unit has formed an alliance with VIB, a Belgium-based life science research institute, in a move that will focus on the commercialisation and supply of new tools and technologies to help meet the evolving needs of translational researchers.
Sean Muthian, the director of Global Strategic Marketing and Partnerships for Sigma-Aldrich, explained, “Too often, valuable research tools that may lead to novel therapeutics or agricultural applications remain within the walls of the originating laboratory. Through our alliance with VIB, we’ll be able to provide scientists with cutting-edge tools and technologies that otherwise would not be available to them in an expedited fashion.”
Beginning this year, the two companies will collaborate to provide the latest emerging tools and technologies that have demonstrated benefit for translational research and solutions to the challenges that scientists face. Utilising Sigma-Aldrich’s R&D and manufacturing capabilities, along with its global distribution network, the alliance will help to accelerate and enhance the commercial development and availability of VIB’s research tools and technologies for researchers.
“Through our work performing basic scientific research into the foundational mechanisms of life and translating these results into medical, agricultural and industrial applications, our scientists often break new ground, developing tools and technologies that solve many contemporary research questions,” said VIB Managing Director Johan Cardoen. “This collaboration with Sigma-Aldrich will ensure that the broader research community can gain from our discoveries, advancing science even further.”
Evident names 5th Annual Image of the Year Award winners
View the six winning entries in Evident's 5th Annual Image of the Year Award — a...
Fellowships and scholarships support women in science
The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing...
2024 GSK Award recognises neurodegeneration researcher
Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in...